{"id":"W3124600345","doi":"10.1200/jco.2021.39.3_suppl.167","title":"Checkmate 577:Health-related quality of life (HRQoL) in a randomized, double-blind phase III study of nivolumab (NIVO) versus placebo (PBO) as adjuvant treatment in patients (pts) with resected esophageal or gastroesophageal junction cancer (EC/GEJC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Nivolumab; Quality of life (healthcare); Adjuvant; Placebo; Esophageal cancer; Randomized controlled trial; Oncology; Cancer; Nursing; Pathology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015931,0.001131113,0.002016094,0.0003800494,0.0002853498,0.0008717909,0.0006842379,0.001209163,0.005320637],"category_scores_gemma":[0.001304065,0.0005549015,0.001285615,0.0003232253,0.000828248,0.0005166339,0.0003076826,0.001878847,0.0006301948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005762755,"about_ca_system_score_gemma":0.001083249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008003242,"about_ca_topic_score_gemma":0.001704413,"domain_scores_codex":[0.9995309,0.0002751483,0.00002728778,0.00006385878,0.00004143854,0.00006138475],"domain_scores_gemma":[0.9993652,0.0002042047,0.0001505282,0.00004258466,0.00004138476,0.0001961968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9691473,0.00981329,0.0007339654,0.0006847256,0.0005992708,0.00002827114,0.00003431529,0.0003760921,0.0050542,0.0000782538,0.0004895518,0.01296078],"study_design_scores_gemma":[0.8992367,0.09631116,0.00222495,0.00002605368,0.0004065699,0.00002040979,0.00001201034,0.000555703,0.0008411904,0.00003826365,0.0003168695,0.000010021],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920466,0.002185484,0.0005330091,0.0002280435,0.0002206706,0.002829605,0.0007352351,0.00009490706,0.001126493],"genre_scores_gemma":[0.9888353,0.001524746,0.001173023,0.0005448836,0.0001970457,0.00495472,0.0008993752,0.00001709648,0.001853787],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005320637,"threshold_uncertainty_score":0.01779932,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1997115398412469,"score_gpt":0.518683180574019,"score_spread":0.3189716407327721,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}